FEATURED TRIALS
Graves' disease
We're conducting a study to see if BHV-1300 is a safe treatment for people with Graves' disease.
Drug: BHV-1300
Age: 18-65
Phase: 1
Parkinson's Disease
Researching an investigational treatment to change the course of Parkinson's disease.
Drug: BHV-8000
Age: 40-85
Phase: 2/3
Generalized Epilepsy
Researching an Investigational Treatment Option for Idiopathic Generalized Epilepsy
Drug: BHV-7000
Age: 18-75
Phase: 3
FOCAL EPILEPSY
Researching an investigational treatment option for Focal Onset Epilepsy
Drug: BHV-7000
Age: 18-75
Phase: 2/3
Major Depressive Disorder
A Study to Evaluate the Efficacy and Safety of BHV-7000 Monotherapy in Major Depressive Disorder
Drug: BHV-7000
Age: 18-75
Phase: 2
OUR FAMILY IS WORKING HARD FOR YOU
Biohaven is a clinical-stage pharmaceutical company.
Throughout his career as a practicing physician, Associate Clinical Professor of Psychiatry and as Biohaven’s Chairman and CEO, Dr. Vlad Coric is dedicated to advancing treatment for brain disorders and other rare and common diseases.
Clinical trials can transform lives.
Finding new treatments that improve people’s health and change lives involves rigorous study in clinical trials before they are approved for use. Being part of a clinical trial has the potential to not only improve the lives of participants, but the lives of others as well.
WE ARE SOCIAL
